Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.36 trillion. The enterprise value is 1.54 trillion.

Market Cap	1.36T
Enterprise Value	1.54T

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Mar 13, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.17%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 13.52 and the forward PE ratio is 21.44.

PE Ratio	13.52
Forward PE	21.44
PS Ratio	3.80
PB Ratio	4.69
P/TBV Ratio	56.79
P/FCF Ratio	19.97
P/OCF Ratio	14.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.42, with an EV/FCF ratio of 22.62.

EV / Earnings	15.31
EV / Sales	4.73
EV / EBITDA	10.42
EV / EBIT	12.58
EV / FCF	22.62

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	5.18%
Revenue Per Employee	4.84M
Profits Per Employee	1.36M
Employee Count	75,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 15.44 billion in taxes.

Income Tax	15.44B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +18.79% in the last 52 weeks. The beta is 0.28, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+18.79%
50-Day Moving Average	76.14
200-Day Moving Average	65.85
Relative Strength Index (RSI)	34.82
Average Volume (20 Days)	4,737

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 358.08 billion and earned 100.54 billion in profits. Earnings per share was 40.10.

Revenue	358.08B
Gross Profit	276.48B
Operating Income	134.76B
Pretax Income	116.04B
Net Income	100.54B
EBITDA	160.31B
EBIT	134.76B
Earnings Per Share (EPS)	40.10

Balance Sheet

The company has 80.22 billion in cash and 278.34 billion in debt, giving a net cash position of -198.12 billion.

Cash & Cash Equivalents	80.22B
Total Debt	278.34B
Net Cash	-198.12B
Net Cash Per Share	n/a
Equity (Book Value)	290.06B
Book Value Per Share	117.09
Working Capital	83.66B

Cash Flow

In the last 12 months, operating cash flow was 90.73 billion and capital expenditures -22.65 billion, giving a free cash flow of 68.08 billion.

Operating Cash Flow	90.73B
Capital Expenditures	-22.65B
Depreciation & Amortization	23.17B
Net Borrowing	56.83B
Free Cash Flow	68.08B
FCF Per Share	n/a

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 1.49, which amounts to a dividend yield of 2.16%.

Dividend Per Share	1.49
Dividend Yield	2.16%
Dividend Growth (YoY)	-2.94%
Years of Dividend Growth	3
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	3.50%
Earnings Yield	7.40%
FCF Yield	5.01%

Dividend Details

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	8

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5